Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Change in Cash (2021 - 2025)

Medicinova (MNOV) has disclosed Change in Cash for 7 consecutive years, with -$834437.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash changed N/A to -$834437.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.5 million, a N/A change, with the full-year FY2025 number at -$9.6 million, up 10.21% from a year prior.
  • Change in Cash was -$834437.0 for Q4 2025 at Medicinova, up from -$3.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $36.8 million in Q1 2023 to a low of -$3.9 million in Q1 2024.
  • A 5-year average of $1.9 million and a median of -$2.2 million in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: crashed 122.97% in 2022, then soared 1083.85% in 2023.
  • Medicinova's Change in Cash stood at -$3.6 million in 2021, then decreased by 3.93% to -$3.7 million in 2022, then skyrocketed by 86.4% to -$507919.0 in 2023, then plummeted by 305.03% to -$2.1 million in 2024, then soared by 59.44% to -$834437.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Change in Cash are -$834437.0 (Q4 2025), -$3.8 million (Q1 2025), and -$2.1 million (Q3 2024).